Providence Swedish Enrolls Patients in National Long COVID Clinical Trial

Providence Swedish is currently taking patient sign-ups for a nationwide clinical research study designed to aid investigators in comprehending and addressing Long COVID, as reported by blog.swedish.org.

Long COVID happens when symptoms continue for months or even years after a COVID-19 infection. Patients experience diverse indicators that can impact multiple physical systems, encompassing breathing, heart function, concentration, memory, and overall energy level.

The study, called REVERSE-LC, is funded by the National Institutes of Health. It is testing whether baricitinib, a medication already cleared by the U.S. Food and Drug Administration for specific ailments, can help improve thinking and memory problems and reduce fatigue in people living with Long COVID.

Baricitinib works by calming parts of the immune system that can drive inflammation. Researchers want to learn whether this approach is safe and helpful for Long COVID symptoms.

“The REVERSE-LC trial is an exciting study that will move the field of Long COVID forward,” said Jason Goldman, M.D., an infectious disease specialist leading Providence Swedish’s participation in the trial. “We need to study baricitinib to help ensure it is safe and effective.”

Individuals may be eligible if they are at least 18 years old and have experienced cognitive or memory difficulties for a minimum of six months following a COVID infection. Out of 17 participating locations nationwide seeking to recruit a total of 550 adults, Providence Swedish stands alone as the sole regional facility in the Pacific Northwest involved in the study.

Participants are randomly assigned to receive either baricitinib or a placebo, which helps researchers compare results fairly. The Patient-Led Research Collaborative, an advocacy group comprising individuals with firsthand experience of Long COVID, provided consultative feedback during the creation of the trial. The study received high marks from the organization for incorporating patient-researchers into the development phase and properly addressing patient priorities.

To find out more information or to see if you are eligible to join REVERSE-LC, you have the option to register for the Swedish Long COVID Registry or send an email to [email protected].

Clinical trials help researchers learn what treatments work, who they help and how safe they are. For individuals managing Long COVID, enrolling in these studies also offers a meaningful opportunity to help generate solutions that might aid other patients.

Kirkland resident Amy Rosas, a 53-year-old mother of two, has taken part in three separate Long COVID clinical studies through Providence Swedish. Her physical wellness, mental well-being, employment capabilities, and engagement in family activities were all disrupted by Long COVID, according to her statements.

“Participation in each clinical trial has cumulatively helped improve my physical and mental health,” Rosas said. “Taking part helps provide personal and collective benefit for everyone affected by this debilitating condition.”

Operating in the Puget Sound area since 1877 when the initial Providence facility was established in Seattle, Providence Swedish later saw the founding of the first Swedish hospital in 1910. Having joined forces through a 2012 affiliation, the two entities now form the most extensive medical network across Western Washington, boasting eight hospitals, 244 clinics stretching from Everett to Centralia, and a workforce of 24,000 caregivers.